Suppr超能文献

在细菌细胞中生产人源RAP30和RAP74。

Production of human RAP30 and RAP74 in bacterial cells.

作者信息

Wang B Q, Kostrub C F, Finkelstein A, Burton Z F

机构信息

Department of Biochemistry, Michigan State University, E. Lansing 48824.

出版信息

Protein Expr Purif. 1993 Jun;4(3):207-14. doi: 10.1006/prep.1993.1027.

Abstract

RAP30 and RAP74 are subunits of RAP30/74 (TFIIF), a general initiation and elongation factor for transcription by RNA polymerase II. Complementary DNA (cDNA) clones have previously been reported encoding human RAP30 and RAP74. Here we report expression of these cDNAs using a T7 RNA polymerase system in Escherichia coli. Production of human RAP30 was very efficient using the expression vector pET11d. RAP30 accumulated within inclusion bodies and was solubilized using guanidine hydrochloride. After removal of the denaturant, RAP30 was soluble and active in accurate transcription. Approximately 44 mg of highly purified and soluble RAP30 was obtained from a 1-liter culture of cells. Production of RAP74 was more problematic, because a mixture of full length RAP74 and RAP74 fragments was produced in E. coli. Most RAP74 fragments were shortened by deletion of the COOH-terminus of the protein and probably resulted from premature translation termination. RAP74 was most successfully produced using a pET23d construct, in which the RAP74 peptide was fused to a short polyhistidine stretch at its COOH-terminus. Addition of the polyhistidine sequence allowed purification using a Ni2+ affinity resin. Full length RAP74 carrying this polyhistidine extension was purified in a single step by Ni2+ affinity chromatography in 4 M urea; the yield of RAP74 was approximately 3 mg from a 1-liter culture of cells. RAP74 derivatized with a polyhistidine stretch at its NH2-terminus, on the other hand, remained contaminated with RAP74 fragments after Ni2+ affinity chromatography.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

RAP30和RAP74是RAP30/74(TFIIF)的亚基,TFIIF是RNA聚合酶II转录的一般起始和延伸因子。此前已有报道称互补DNA(cDNA)克隆编码人类RAP30和RAP74。在此,我们报告了使用T7 RNA聚合酶系统在大肠杆菌中表达这些cDNA的情况。使用表达载体pET11d生产人类RAP30非常高效。RAP30在包涵体内积累,并用盐酸胍溶解。去除变性剂后,RAP30可溶且在精确转录中具有活性。从1升细胞培养物中获得了约44毫克高度纯化且可溶的RAP30。RAP74的生产则更成问题,因为在大肠杆菌中产生了全长RAP74和RAP74片段的混合物。大多数RAP74片段因蛋白质COOH末端的缺失而缩短,可能是由于过早的翻译终止。使用pET23d构建体生产RAP74最为成功,其中RAP74肽在其COOH末端与一段短的多组氨酸序列融合。多组氨酸序列的添加使得可以使用Ni2+亲和树脂进行纯化。携带这种多组氨酸延伸的全长RAP74通过在4 M尿素中进行Ni2+亲和层析一步纯化;从1升细胞培养物中获得的RAP74产量约为3毫克。另一方面,在其NH2末端带有多组氨酸延伸的RAP74在Ni2+亲和层析后仍被RAP74片段污染。(摘要截短至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验